Segrestaa J M, Caulin C, Dahan R, Houlbert D, Thiercelin J F, Herman P, Sauvanet J P, Larribaud J
Eur J Clin Pharmacol. 1984;26(4):481-3. doi: 10.1007/BF00542145.
The effect of the calcium antagonist, diltiazem, on glycoregulation was investigated in 12 healthy volunteers using a standard glucose tolerance test. No significant change was observed in plasma glucose, insulin or glucagon levels after oral treatment for B days with diltiazem 180 mg/day.